Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Solko Schalm

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Procedures

Concepts & Ideas

Treatment Outcome

Anatomy

Liver

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
72
de Man, Robert
66
Heijtink, Rudolf
48
Janssen, Harry
38
Hansen, Bettina
34
Brouwer, Johannes
31
Niesters, Hubert
25
Terpstra, Onno
17
van Buuren, Henk
17
Zeuzem, Stefan
12
Hop, Wim
11
Neumann, Avidan
10
Fattovich, Giovanna
10
van Zonneveld, Monika
10
Veldt, Bart
10
Vrolijk, Jan

Sign-in to see all Coauthors

Publications

TOP 3
Toy Mehlika; Veldhuijzen Irene K; de Man Robert A; Richardus Jan Hendrik; Schalm Solko W
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Schalm S W; Buster E H C J
[The practice guideline 'Viral hepatitis and other liver diseases' (second revision) from the Dutch College of General Practitioners; a response from the perspective of gastroenterology]
Leemans Wilhelmus F; Niesters Hubert G; van der Eijk Annemiek A; Janssen Harry L; Schalm Solko W; de Man Robert A
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Solko Schalm (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Toy Mehlika; Veldhuijzen Irene K; de Man Robert A; Richardus Jan Hendrik; Schalm Solko W
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Hepatology (Baltimore, Md.) 2009;50(3):743-51.
2008: Schalm S W; Buster E H C J
[The practice guideline 'Viral hepatitis and other liver diseases' (second revision) from the Dutch College of General Practitioners; a response from the perspective of gastroenterology]
Nederlands tijdschrift voor geneeskunde 2008;152(49):2658-61.
2008: Leemans Wilhelmus F; Niesters Hubert G; van der Eijk Annemiek A; Janssen Harry L; Schalm Solko W; de Man Robert A
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
European journal of gastroenterology & hepatology 2008;20(8):773-7.
2008: de Bruijne J; Buster E H C J; Gelderblom H C; Brouwer J T; de Knegt R J; van Erpecum K J; Schalm S W; Bakker C M; Zaaijer H L; Janssen H L A; Reesink H W;
Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
The Netherlands journal of medicine 2008;66(7):311-22.
2008: Buster E H C J; van Erpecum K J; Schalm S W; Zaaijer H L; Brouwer J T; Gelderblom H C; de Knegt R J; Minke Bakker C; Reesink H W; Janssen H L A;
Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
The Netherlands journal of medicine 2008;66(7):292-306.
2008: Veldt Bart J; Chen Wendong; Heathcote E Jenny; Wedemeyer Heiner; Reichen Juerg; Hofmann W Peter; de Knegt Robert J; Zeuzem Stefan; Manns Michael P; Hansen Bettina E; Schalm Solko W; Janssen Harry L A
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Hepatology (Baltimore, Md.) 2008;47(6):1856-62.
2008: Pugnale Paolo; Herrmann Eva; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Ferrari Carlo; Homburger Yonit; Zeuzem Stefan; Negro Francesco;
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
Journal of hepatology 2008;48(6):932-8.
2008: Idris Berlian I; Brosa Max; Richardus Jan H; Esteban Rafael; Schalm Solko W; Buti Maria
Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
European journal of gastroenterology & hepatology 2008;20(4):320-6.
2008: van Leusen Robert; Adang Rob P R; de Vries Richard A; Cnossen Trijntje T; Konings Constantijn J A M; Schalm Solko W; Tan Adriaan C I T L
Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(2):721-5.
2008: Westin Johan; Ydreborg Magdalena; Islam Sara; Alsiö Asa; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; Ferrari Carlo; Neumann Avidan U; Hellstrand Kristoffer; Lagging Martin;
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.
Scandinavian journal of gastroenterology 2008;43(1):73-80.
2008: Buster Erik H C J; Schalm Solko W; Janssen Harry L A
Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
Best practice & research. Clinical gastroenterology 2008;22(6):1093-108.
2007: Veldt Bart J; Heathcote E Jenny; Wedemeyer Heiner; Reichen Juerg; Hofmann W Peter; Zeuzem Stefan; Manns Michael P; Hansen Bettina E; Schalm Solko W; Janssen Harry L A
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
Annals of internal medicine 2007;147(10):677-84.
2007: Bergmann Jilling F; Vrolijk Jan M; van der Schaar Peter; Vroom Brigitte; van Hoek Bart; van der Sluys Veer Annet; de Vries Richard A; Verhey Elke; Hansen Bettina E; Brouwer Johannes T; Janssen Harry L A; Schalm Solko W; de Knegt Robert J
Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(9):1217-25.
2007: Pilli Massimo; Zerbini Alessandro; Penna Amalia; Orlandini Alessandra; Lukasiewicz Esther; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; von Wagner Michael; Germanidis Georgios; Lurie Yoav; Esteban Juan I; Haagmans Bart L; Hezode Christophe; Lagging Martin; Negro Francesco; Homburger Yonit; Neumann Avidan U; Ferrari Carlo; Missale Gabriele;
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
Gastroenterology 2007;133(4):1132-43.
2007: Sprengers D; van der Molen R G; Binda R; Kusters J G; de Man R A; Niesters H G M; Schalm S W; Janssen H L A
In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection.
Journal of viral hepatitis 2007;14(10):743-9.
2007: Flink H J; Buster E H C J; Merican I; Nevens F; Kitis G; Cianciara J; de Vries R A; Hansen B E; Schalm S W; Janssen H L A
Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
Gut 2007;56(10):1485-6.
2007: Buster Erik H C J; Hansen Bettina E; Buti Maria; Delwaide Jean; Niederau Claus; Michielsen Peter P; Flisiak Robert; Zondervan Pieter E; Schalm Solko W; Janssen Harry L A;
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
Hepatology (Baltimore, Md.) 2007;46(2):388-94.
2007: Hou Jinlin; Schilling Ralf; Janssen Harry L A; Hansen Bettina E; Heijtink Rudolf; Sablon Erwin; Williams Roger; Lau George K K; Schalm Solko W; Naoumov Nikolai V
Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
Journal of medical virology 2007;79(8):1055-63.
2007: Westin Johan; Hellstrand Kristoffer; Alsiö Asa; Ydreborg Magdalena; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Verhey-Hart Elke; Lagging Martin
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2007;45(5):1333-4; author reply 1334.
2007: Buster E H C J; van der Eijk A A; de Man R A; Janssen H L A; Schalm S W
Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety.
Journal of viral hepatitis 2007;14(5):350-4.
2007: Veldt Bart J; Schalm Solko W; Janssen Harry L A
Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon.
Journal of clinical gastroenterology 2007;41(4):432.
2007: van der Plas Simone M; Hansen Bettina E; de Boer Josien B; Stijnen Theo; Passchier Jan; de Man Rob A; Schalm Solko W
Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(3):375-88.
2007: Westin J; Lagging M; Dhillon A P; Norkrans G; Romero A I; Pawlotsky J-M; Zeuzem S; Schalm S W; Verheij-Hart E; Negro F; Missale G; Neumann A U; Hellstrand K;
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
Journal of viral hepatitis 2007;14(1):29-35.
2007: Lukasiewicz Esther; Hellstrand Kristoffer; Westin Johan; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Veldt Bart J; Hansen Bettina E; Verhey-Hart Elke; Lagging Martin
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Hepatology (Baltimore, Md.) 2007;45(1):258-9.
2007: ter Borg Martijn J; Hansen Bettina E; Herrmann Eva; Zeuzem Stefan; Cakaloglu Yilmaz; Karayalcin Selim; Flisiak Robert; van' t Veen Annemarie; de Man Robert A; Schalm Solko W; Janssen Harry La; Haagmans Bart L;
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
Antiviral therapy 2007;12(8):1285-94.
2006: Lagging Martin; Romero Ana I; Westin Johan; Norkrans Gunnar; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; von Wagner Michael; Negro Francesco; Schalm Solko W; Haagmans Bart L; Ferrari Carlo; Missale Gabriele; Neumann Avidan U; Verheij-Hart Elke; Hellstrand Kristoffer;
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
Hepatology (Baltimore, Md.) 2006;44(6):1617-25.
2006: Flink Hajo J; Hansen Bettina E; Heathcote E Jenny; Feinman S Victor; Simsek Halis; Karayalcin Selim; Mach Tomasz; Leemans Wim F; de Man Robert A; Verhey Elke; Schalm Solko W; Janssen Harry L A;
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.
The American journal of gastroenterology 2006;101(11):2523-9.
2006: Romero Ana I; Lagging Martin; Westin Johan; Dhillon Amar P; Dustin Lynn B; Pawlotsky Jean-Michel; Neumann Avidan U; Ferrari Carlo; Missale Gabriele; Haagmans Bart L; Schalm Solko W; Zeuzem Stefan; Negro Francesco; Verheij-Hart Elke; Hellstrand Kristoffer;
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
The Journal of infectious diseases 2006;194(7):895-903.
2006: Orlent Hans; Hansen Bettina E; Willems Marc; Brouwer Johannes T; Huber Roman; Kullak-Ublick Gerd A; Gerken Guido; Zeuzem Stefan; Nevens Frederik; Tielemans Wanda C M; Zondervan Pieter E; Lagging Martin; Westin Johan; Schalm Solko W
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
Journal of hepatology 2006;45(4):539-46.
2006: ter Borg Martijn J; van Zonneveld Monika; Zeuzem Stefan; Senturk Hakan; Akarca Ulus S; Simon Christopher; Hansen Bettina E; Haagmans Bart L; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.
Hepatology (Baltimore, Md.) 2006;44(3):721-7.
2006: Veldt Bart J; Hansen Bettina E; Ikeda Kenji; Verhey Elke; Suzuki Hiroshi; Schalm Solko W
Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.
Scandinavian journal of gastroenterology 2006;41(9):1087-94.
2006: ter Borg Pieter C J; Schalm Solko W; Hansen Bettina E; van Buuren Henk R;
Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
The American journal of gastroenterology 2006;101(9):2044-50.
2006: Sprengers Dave; van der Molen Renate G; Kusters Johannes G; De Man Robert A; Niesters Hubert G M; Schalm Solko W; Janssen Harry L A
Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
Journal of hepatology 2006;45(2):182-9.
2006: Gutteling J J; de Man R A; van der Plas S M; Schalm S W; Busschbach J J V; Darlington A-S E
Determinants of quality of life in chronic liver patients.
Alimentary pharmacology & therapeutics 2006;23(11):1629-35.
2006: van Zonneveld Monika; Zondervan Pieter E; Cakaloglu Yilmaz; Simon Christopher; Akarca Ulus S; So Thomas M K; Flink Hajo J; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(4):399-405.
2006: Sprengers D; van der Molen R G; Kusters J G; Hansen B; Niesters H G M; Schalm S W; Janssen H L A
Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
Journal of medical virology 2006;78(5):561-8.
2006: Leemans Wilhelmus F; Flink Hajo J; Janssen Harry L A; Niesters Hubert G M; Schalm Solko W; de Man Robert A
The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.
Journal of hepatology 2006;44(3):507-11.
2006: Flink Hajo J; van Zonneveld Monika; Hansen Bettina E; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.
The American journal of gastroenterology 2006;101(2):297-303.
2006: van der Eijk A A; Niesters H G M; Hansen B E; Heijtink R A; Janssen H L A; Schalm S W; de Man R A
Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
Journal of viral hepatitis 2006;13(2):96-103.
2006: van der Eijk A A; de Man R A; Niesters H G M; Schalm S W; Zaaijer H L
Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers.
Journal of viral hepatitis 2006;13(1):2-4.
2005: van der Eijk Annemiek A; Niesters Hubert G M; Hansen Bettina E; Pas Suzan D; Richardus Jan H; Mostert Marijke; Janssen Harry L A; Schalm Solko W; de Man Robert A
Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients.
European journal of gastroenterology & hepatology 2005;17(11):1173-9.
2005: Flink H J; Sprengers D; Hansen B E; van Zonneveld M; de Man R A; Schalm S W; Janssen H L A;
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
Gut 2005;54(11):1604-9.
2005: Orlent Hans; Mathot Ron A; Van Bommel Eric F; Vulto Arnold G; Schalm Solko W; Brouwer Johannes T
Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.
Digestive diseases and sciences 2005;50(10):1804-6.
2005: Sprengers D; van der Molen R G; Kusters J G; Kwekkeboom J; van der Laan L J W; Niesters H G M; Kuipers E J; De Man R A; Schalm S W; Janssen H L A
Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis.
Journal of viral hepatitis 2005;12(5):507-12.
2005: Zeuzem Stefan; Pawlotsky Jean-Michel; Lukasiewicz Esther; von Wagner Michael; Goulis Ioannis; Lurie Yoav; Gianfranco Elia; Vrolijk Jan-Maarten; Esteban Juan I; Hezode Christophe; Lagging Martin; Negro Francesco; Soulier Alexandre; Verheij-Hart Elke; Hansen Bettina; Tal Ronen; Ferrari Carlo; Schalm Solko W; Neumann Avidan U;
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.
Journal of hepatology 2005;43(2):250-7.
2005: Rave Sjoerd; Schalm Solko W;
The optimal timing of liver transplantation in patients with chronic cholestatic liver disease.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(8):937-40.
2005: van der Eijk A A; Hansen B E; Niesters H G M; Janssen H L A; van de Ende M; Schalm S W; de Man R A
Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
Journal of viral hepatitis 2005;12(4):364-72.
2005: Tang Thjon J; Kwekkeboom Jaap; Mancham Shanta; Binda Rekha S; de Man Robert A; Schalm Solko W; Kusters Johannes G; Janssen Harry L A
Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection.
Journal of hepatology 2005;43(1):45-52.
2005: van Zonneveld M; Flink H J; Verhey E; Senturk H; Zeuzem S; Akarca U S; Cakaloglu Y; Simon C; So T M K; Gerken G; de Man R A; Hansen B E; Schalm S W; Janssen H L A;
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
Alimentary pharmacology & therapeutics 2005;21(9):1163-71.
2005: de Rave Sjoerd; Hansen Bettina E; Groenland Theo H N; Kazemier Geert; de Man Robert A; Metselaar Herold J; Terpstra Onno T; Tilanus Hugo W; Ijzermans Jan H N M; Schalm Solko W
Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(4):396-401.
2005: Veldt B J; Hansen B E; Eijkemans M J C; de Knegt R J; Stijnen T; Habbema J D F; Schalm S W
Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C.
Alimentary pharmacology & therapeutics 2005;21(5):539-47.
2005: Janssen Harry L A; van Zonneveld Monika; Senturk Hakan; Zeuzem Stefan; Akarca Ulus S; Cakaloglu Yilmaz; Simon Christopher; So Thomas M K; Gerken Guido; de Man Robert A; Niesters Hubert G M; Zondervan Pieter; Hansen Bettina; Schalm Solko W;
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
Lancet 2005;365(9454):123-9.
2005: de Rave S; Vrolijk J M; Schalm S W
The optimal treatment strategy for chronic hepatitis C.
Medical hypotheses 2005;65(2):238-42.
2004: van der Plas Simone M; Hansen Bettina E; de Boer Josien B; Stijnen Theo; Passchier Jan; de Man Rob A; Schalm Solko W
The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(8):1469-81.
2004: Veldt B J; Saracco G; Boyer N; Cammà C; Bellobuono A; Hopf U; Castillo I; Weiland O; Nevens F; Hansen B E; Schalm S W
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.
Gut 2004;53(10):1504-8.
2004: Janssen Harry L A; van Zonneveld Monika; van Nunen Andeltje B; Niesters Hubert G M; Schalm Solko W; de Man Robert A
Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
European journal of gastroenterology & hepatology 2004;16(8):801-7.
2004: Vrolijk J M; Tang T J; Kwekkeboom J; Haagmans B L; Herscheid A J; Kusters J G; Janssen H L A; Brouwer J T; Schalm S W
Monitoring intrahepatic CD8+ T cells by fine-needle aspiration cytology in chronic hepatitis C infection.
Journal of viral hepatitis 2004;11(4):342-8.
2004: Janssen Harry L A; van Zonneveld Monika; Schalm Solko W
Hepatitis B.
The New England journal of medicine 2004;350(26):2719-20.
2004: Brouwer Johannes T; Nevens Frederik; Bekkering Frank C; Bourgeois Nadine; Van Vlierberghe Hans; Weegink Christine J; Lefebvre Véronique; Van Hattum Jan; Henrion Jean; Delwaide Jean; Hansen Bettina E; Schalm Solko W; For The Benelux Study Group On Treatment Of Chronic Hepatitis C
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Journal of hepatology 2004;40(4):689-95.
2004: Vrolijk J M; de Knegt R J; Veldt B J; Orlent H; Schalm S W
The treatment of hepatitis C: history, presence and future.
The Netherlands journal of medicine 2004;62(3):76-82.
2004: van Zonneveld Monika; Honkoop Pieter; Hansen Bettina E; Niesters Hubertus G M; Darwish Murad Sarwa; de Man Robert A; Schalm Solko W; Janssen Harry L A
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 2004;39(3):804-10.
2004: van der Eijk Annemiek A; Niesters Hubert G M; Götz Hannelore M; Janssen Harry L A; Schalm Solko W; Osterhaus Albert D M E; de Man Robert A
Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;29(2):92-4.
2004: Tang Thjon J; de Man Robert A; Kusters Johannes G; Kwekkeboom Jaap; Hop Wim C J; van der Molen Renate G; Schalm Solko W; Janssen Harry L A
Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
Journal of medical virology 2004;72(2):215-22.
2004: Tanis W; Mancham S; Binda R; Janssen H L A; Bezemer G; IJzermans J N M; Tilanus H W; Laman J D; de Wit H; Drexhage H A; Schalm S W; Kwekkeboom J
Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells.
Clinical immunology (Orlando, Fla.) 2004;110(1):81-8.
2004: Buster E H C J; van der Eijk A A; de Man R A; Schalm S W
Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention.
Scandinavian journal of gastroenterology. Supplement 2004;(241):45-9.
2003: Vrolijk Jan M; Kwekkeboom Jaap; Janssen Harry L A; Hansen Bettina E; Zondervan Pieter E; Osterhaus Albert D M E; Schalm Solko W; Haagmans Bart L
Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection.
The Journal of infectious diseases 2003;188(10):1528-32.
2003: van der Plas Simone M; Hansen Bettina E; de Boer Josien B; Stijnen Theo; Passchier Jan; de Man Robert A; Schalm Solko W
Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study.
BMC gastroenterology 2003;3():33.
2003: Buster E H C J; van der Eijk A A; Schalm S W
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.
Antiviral research 2003;60(2):79-85.
2003: Tang Thjon J; Janssen Harry L A; Kusters Johannes G; de Man Robert A; Schalm Solko W; Kwekkeboom Jaap
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique.
FEMS immunology and medical microbiology 2003;39(1):69-72.
2003: Veldt Bart J; Brouwer Johannes T; Adler Michael; Nevens Frederik; Michielsen Peter; Delwaide Jean; Hansen Bettina E; Schalm Solko W;
Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378].
BMC gastroenterology 2003;3():24.
2003: van Buuren Henk R; Rasch Marijke C; Batenburg Piet L; Bolwerk Clemens J M; Nicolai Jan J; van der Werf Sjoerd D J; Scherpenisse Joost; Arends Lidia R; van Hattum Jan; Rauws Erik A J; Schalm Solko W
Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899].
BMC gastroenterology 2003;3():22.
2003: Schalm S W; Buster E H C J
Management of hepatitis B virus infected health care workers based on HBV DNA levels.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;27(3):231-4.
2003: van Zonneveld M; van Nunen A B; Niesters H G M; de Man R A; Schalm S W; Janssen H L A
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
Journal of viral hepatitis 2003;10(4):294-7.
2003: Orlent H; Vrolijk J M; de Man R A; Schalm S W
[The treatment of hepatitis C]
Nederlands tijdschrift voor geneeskunde 2003;147(25):1208-13.
2003: Vrolijk Jan M; Kaul Artur; Hansen Bettina E; Lohmann Volker; Haagmans Bart L; Schalm Solko W; Bartenschlager Ralf
A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.
Journal of virological methods 2003;110(2):201-9.
2003: Vrolijk J M; Bekkering F C; Brouwer J T; Hansen B E; Schalm S W
High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy.
Journal of viral hepatitis 2003;10(3):205-9.
2003: Tang T J; Kwekkeboom J; Laman J D; Niesters H G M; Zondervan P E; de Man R A; Schalm S W; Janssen H L A
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection.
Journal of viral hepatitis 2003;10(3):159-67.
2003: van Nunen A B; Hansen B E; Suh D J; Löhr H F; Chemello L; Fontaine H; Heathcote J; Song B C; Janssen H L A; de Man R A; Schalm S W
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
Gut 2003;52(3):420-4.
2003: Sprengers D; Janssen H L A; Kwekkeboom J; Niesters H G M; de Man R A; Schalm S W
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.
Journal of viral hepatitis 2003;10(1):7-9.
2003: Orlent H; Vrolijk J M; Veldt B J; Schalm S W
Hepatitis C 2002 guidelines: summary and annotations.
Scandinavian journal of gastroenterology. Supplement 2003;(239):105-10.
2003: Schalm Solko W
Combination therapy for chronic hepatitis B.
Journal of hepatology 2003;39 Suppl 1():S146-50.
2002: Schalm S W; De Man R A; Janssen H L A
Combination and newer therapies for chronic hepatitis B.
Journal of gastroenterology and hepatology 2002;17 Suppl 3():S338-41.
2002: Fattovich Giovanna; Pantalena Maurizio; Zagni Irene; Realdi Giuseppe; Schalm Solko W; Christensen Erik;
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
The American journal of gastroenterology 2002;97(11):2886-95.
2002: Quero Guillén J C; Groeneweg M; Jiménez Sáenz M; Schalm S W; Herrerías Gutiérrez J M
Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2002;94(9):544-57.
2002: Hussain Shahid M; Zondervan Pieter E; IJzermans Jan N M; Schalm Solko W; de Man Rob A; Krestin Gabriel P
Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
Radiographics : a review publication of the Radiological Society of North America, Inc 2002;22(5):1023-36; discussion 1037-9.
2002: Wolters Leonieke M M; Hansen Bettina E; Niesters Hubert G M; Levi-Drummer Rachel S; Neumann Avidan U; Schalm Solko W; de Man Robert A
The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine.
Journal of hepatology 2002;37(2):253-8.
2002: Perrillo Robert P; Lai Ching-Lung; Liaw Yun-Fan; Dienstag Jules L; Schiff Eugene R; Schalm Solko W; Heathcote E Jenny; Brown Nathaniel A; Atkins Mark; Woessner Mary; Gardner Stephen D
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
Hepatology (Baltimore, Md.) 2002;36(1):186-94.
2002: van der Eijk A A; Doorduijn J K; Janssen H L A; Schalm S W; Niesters H G M; de Man R A
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]
Nederlands tijdschrift voor geneeskunde 2002;146(24):1140-4.
2002: Janssen Harry L A; Tan Adriaan C I T L; Tilanus Hugo W; Metselaar Herold J; Zondervan Pieter E; Schalm Solko W
Pseudo-Budd-Chiari Syndrome: decompensated alcoholic liver disease mimicking hepatic venous outflow obstruction.
Hepato-gastroenterology 2002;49(45):810-2.
2002: van Nunen A B; de Man R A; Heijtink R A; Vossen A C T M; Schalm S W
Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?
Journal of viral hepatitis 2002;9(3):221-8.
2002: Wolters Lonieke M M; Hansen Bettina E; Niesters Hubert G M; Zeuzem Stefan; Schalm Solko W; de Man Robert A
Viral dynamics in chronic hepatitis B patients during lamivudine therapy.
Liver 2002;22(2):121-6.
2002: Willems M; Metselaar H J; Tilanus H W; Schalm S W; de Man R A
Liver transplantation and hepatitis C.
Transplant international : official journal of the European Society for Organ Transplantation 2002;15(2-3):61-72.
2001: van Nunen A B; Janssen H L; Wolters L M; Niesters H G; de Man R A; Schalm S W
Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?
Antiviral research 2001;52(2):139-46.
2001: van Rossum T G; Vulto A G; Hop W C; Schalm S W
Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.
The American journal of gastroenterology 2001;96(8):2432-7.
2001: van Rossum T G; de Jong F H; Hop W C; Boomsma F; Schalm S W
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients.
Journal of gastroenterology and hepatology 2001;16(7):789-95.
2001: Heijtink R A; van Bergen P; van Roosmalen M H; Sünnen C M; Paulij W P; Schalm S W; Osterhaus A D
Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.
Vaccine 2001;19(27):3671-80.
2001: Fattovich G; Ribero M L; Pantalena M; Diodati G; Almasio P; Nevens F; Tremolada F; Degos F; Rai J; Solinas A; Mura D; Tocco A; Zagni I; Fabris F; Lomonaco L; Noventa F; Realdi G; Schalm S W; Tagger A;
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe.
Journal of viral hepatitis 2001;8(3):206-16.
2001: Bekkering F C; Brouwer J T; Hansen B E; Schalm S W
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin.
Journal of hepatology 2001;34(3):435-40.
2001: Heijtink R A; Janssen H L; Hop W C; Osterhaus A D; Schalm S W
Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication.
Journal of medical virology 2001;63(3):217-9.
2001: Tan A C; Brouwer J T; Glue P; van Leusen R; Kauffmann R H; Schalm S W; de Vries R A; Vroom B
Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(1):193-5.
2001: Bekkering F C; Neumann A U; Brouwer J T; Levi-Drummer R S; Schalm S W
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control study.
BMC gastroenterology 2001;1():14.
2000: van Buuren H R; van Hoogstraten HJE; Terkivatan T; Schalm S W; Vleggaar F P
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis.
Journal of hepatology 2000;33(4):543-8.
2000: Heijtink R A; Janssen H L; Hop W C; Osterhaus A D; Schalm S W
Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.
Journal of viral hepatitis 2000;7(5):382-6.
2000: Honkoop P; de Man R A; Niesters H G; Zondervan P E; Schalm S W
Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.
Hepatology (Baltimore, Md.) 2000;32(3):635-9.
2000: Wolfhagen F H; van Buuren H R; Vleggaar F P; Schalm S W
Management of osteoporosis in primary biliary cirrhosis.
Baillière's best practice & research. Clinical gastroenterology 2000;14(4):629-41.
2000: Hartmann I J; Groeneweg M; Quero J C; Beijeman S J; de Man R A; Hop W C; Schalm S W
The prognostic significance of subclinical hepatic encephalopathy.
The American journal of gastroenterology 2000;95(8):2029-34.
2000: van Hoogstraten H J; Vleggaar F P; Boland G J; van Steenbergen W; Griffioen P; Hop W C; van Hattum J; van Berge Henegouwen G P; Schalm S W; van Buuren H R
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
The American journal of gastroenterology 2000;95(8):2015-22.
2000: Schalm S W; van Wijngaarden J K
Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution?
Journal of viral hepatitis 2000;7(4):245-9.
2000: van Nunen A B; de Man R A; Heijtink R A; Niesters H G; Schalm S W
Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients.
Journal of hepatology 2000;32(6):1040-1.
2000: Groeneweg M; Moerland W; Quero J C; Hop W C; Krabbe P F; Schalm S W
Screening of subclinical hepatic encephalopathy.
Journal of hepatology 2000;32(5):748-53.
2000: Schalm S W; Wolters L M; van Nunen A B; Niesters H G; de Man R A
New nucleoside analogues for chronic hepatitis B.
Acta gastro-enterologica Belgica 2000;63(2):191-3.
2000: Schalm S W; Heathcote J; Cianciara J; Farrell G; Sherman M; Willems B; Dhillon A; Moorat A; Barber J; Gray D F
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial.
Gut 2000;46(4):562-8.
2000: Fattovich G; Giustina G; Christensen E; Pantalena M; Zagni I; Realdi G; Schalm S W
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep).
Gut 2000;46(3):420-6.
2000: Depraetere S; Van Kerschaever E; Van Vlierberghe H; Elewaut A; Brouwer J T; Niesters H G; Schalm S W; Maertens G; Leroux-Roels G
Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers.
Journal of medical virology 2000;60(2):126-32.
1999: van Rossum T G; Vulto A G; Hop W C; Schalm S W
Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection.
Clinical therapeutics 1999;21(12):2080-90.
1999: van Rossum T G; Vulto A G; Hop W C; Brouwer J T; Niesters H G; Schalm S W
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial.
Journal of gastroenterology and hepatology 1999;14(11):1093-9.
1999: de Man R A; Honkoop P; Janssen H L; Schalm S W
[Chronic hepatitis-b-virus infections: new options for antiviral therapy]
Nederlands tijdschrift voor geneeskunde 1999;143(37):1857-61.
1999: van Hoogstraten H J; Hansen B E; van Buuren H R; ten Kate F J; van Berge-Henegouwen G P; Schalm S W
Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group.
Journal of hepatology 1999;31(2):256-62.
1999: Schalm S W; Weiland O; Hansen B E; Milella M; Lai M Y; Hollander A; Michielsen P P; Bellobuono A; Chemello L; Pastore G; Chen D S; Brouwer J T
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.
Gastroenterology 1999;117(2):408-13.
1999: Janssen H L; Gerken G; Carreño V; Marcellin P; Naoumov N V; Craxi A; Ring-Larsen H; Kitis G; van Hattum J; de Vries R A; Michielsen P P; ten Kate F J; Hop W C; Heijtink R A; Honkoop P; Schalm S W
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Hepatology (Baltimore, Md.) 1999;30(1):238-43.
1999: Vleggaar F P; van Buuren H R; Wolfhagen F H; Schalm S W; Pols H A
Prevention and treatment of osteoporosis in primary biliary cirrhosis.
European journal of gastroenterology & hepatology 1999;11(6):617-21.
1999: Wolters L M; Niesters H G; de Man R A; Schalm S W
Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?
Antiviral research 1999;42(1):71-6.
1999: Heijtink R A; Paulij W; van Roosmalen M; Hellings J A; Niesters H G; Schalm S W; Osterhaus A D
Characteristics of the early phase of chronicity in acute hepatitis B infection.
Journal of medical virology 1999;57(4):331-6.
1999: Brouwer J T; Hansen B E; Niesters H G; Schalm S W
Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.
Journal of hepatology 1999;30(2):192-8.
1999: Schalm S W; Brouwer J T; Bekkering F C; van Rossum T G
New treatment strategies in non-responder patients with chronic hepatitis C.
Journal of hepatology 1999;31 Suppl 1():184-8.
1998: Wolfhagen F H; van Hoogstraten H J; van Buuren H R; van Berge-Henegouwen G P; ten Kate F J; Hop W C; van der Hoek E W; Kerbert M J; van Lijf H H; den Ouden J W; Smit A M; de Vries R A; van Zanten R A; Schalm S W
Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.
Journal of hepatology 1998;29(5):736-42.
1998: Schalm S W
Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.
Gut 1998;43(5):602.
1998: Schalm S W; Brouwer J T
Up to date treatment of hepatitis C in adults.
Acta gastro-enterologica Belgica 1998;61(4):397-9.
1998: Van Hoogstraten H J; De Smet M B; Renooij W; Breed J G; Engels L G; Den Ouden-Muller J W; Rijk M C; Smit A M; Zwertbroek R; Hop W C; van Berge Henegouwen G P; Schalm S W; van Buuren H R
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group.
Alimentary pharmacology & therapeutics 1998;12(10):965-71.
1998: Honkoop P; de Man R A; Niesters H G; Main J; Nevens F; Thomas H C; Fevery J; Tyrrell D L; Schalm S W
Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy.
Journal of viral hepatitis 1998;5(5):307-12.
1998: Honkoop P; de Man R A; Niesters H G; Schalm S W
Clinical impact of lamivudine resistance in chronic hepatitis B.
Journal of hepatology 1998;29(3):510-1.
1998: van Hoogstraten H J; Wolfhagen F H; van de Meeberg P C; Kuiper H; Nix G A; Becx M C; Hoek A C; van Houte D P; Rijk M C; Salemans J M; Scherpenisse J; Schrijver M; Smit A M; Spoelstra P; Stadhouders P H; Tan T G; Hop W C; ten Kate F J; vanBerge-Henegouwen G P; Schalm S W; van Buuren H R
Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.
Journal of hepatology 1998;29(3):417-23.
1998: Groeneweg M; Quero J C; De Bruijn I; Hartmann I J; Essink-bot M L; Hop W C; Schalm S W
Subclinical hepatic encephalopathy impairs daily functioning.
Hepatology (Baltimore, Md.) 1998;28(1):45-9.
1998: Bekkering F C; Brouwer J T; Leroux-Roels G; Van Vlierberghe H; Elewaut A; Schalm S W
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.
Journal of hepatology 1998;28(6):960-4.
1998: Brouwer J T; Nevens F; Kleter B; Elewaut A; Adler M; Brenard R; Chamuleau R A; Michielsen P P; Pirotte J; Hautekeete M L; Weber J; Bourgeois N; Hansen B E; Bronkhorst C M; ten Kate F J; Heijtink R A; Fevery J; Schalm S W
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
Journal of hepatology 1998;28(6):951-9.
1998: Fattovich G; Giustina G; Sanchez-Tapias J; Quero C; Mas A; Olivotto P G; Solinas A; Almasio P; Hadziyannis S; Degos F; de Moura M C; Krogsgaard K; Pantalena M; Realdi G; Corrocher R; Schalm S W
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP)
The American journal of gastroenterology 1998;93(6):896-900.
1998: Niesters H G; Honkoop P; Haagsma E B; de Man R A; Schalm S W; Osterhaus A D
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.
The Journal of infectious diseases 1998;177(5):1382-5.
1998: van Rossum T G; Vulto A G; de Man R A; Brouwer J T; Schalm S W
Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.
Alimentary pharmacology & therapeutics 1998;12(3):199-205.
1998: Kleter B; Brouwer J T; Nevens F; van Doorn L J; Elewaut A; Versieck J; Michielsen P P; Hautekeete M L; Chamuleau R A; Brénard R; Bourgeois N; Adler M; Quint W G; Bronkhorst C M; Heijtink R A; Hop W J; Fevery J; Schalm S W
Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C.
Liver 1998;18(1):32-8.
1998: Vleggaar F P; van Buuren H R; Schalm S W
Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population.
European journal of gastroenterology & hepatology 1998;10(1):81-5.
1997: Bekkering F C; Brouwer J T; Schalm S W; Elewaut A
Hepatitis C: viral kinetics.
Hepatology (Baltimore, Md.) 1997;26(6):1691-3.
1997: Tan A C; Kauffmann R H; van Leusen R; Mulder C J; Schalm S W; de Vries R A; Vroom B C
[Chronic hepatitis C in hemodialysis patients]
Nederlands tijdschrift voor geneeskunde 1997;141(47):2280-5.
1997: Heijtink R A; Kruining J; Honkoop P; Kuhns M C; Hop W C; Osterhaus A D; Schalm S W
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.
Journal of medical virology 1997;53(3):282-7.
1997: Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm S W
Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
Hepatology (Baltimore, Md.) 1997;26(5):1338-42.
1997: del Canho R; Grosheide P M; Mazel J A; Heijtink R A; Hop W C; Gerards L J; de Gast G C; Fetter W P; Zwijneberg J; Schalm S W
Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity.
Vaccine 1997;15(15):1624-30.
1997: Schalm S W; Fattovich G; Brouwer J T
Therapy of hepatitis C: patients with cirrhosis.
Hepatology (Baltimore, Md.) 1997;26(3 Suppl 1):128S-132S.
1997: Fattovich G; Giustina G; Degos F; Diodati G; Tremolada F; Nevens F; Almasio P; Solinas A; Brouwer J T; Thomas H; Realdi G; Corrocher R; Schalm S W
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP).
Journal of hepatology 1997;27(1):201-5.
1997: Schalm S W; Hansen B E; Chemello L; Bellobuono A; Brouwer J T; Weiland O; Cavalletto L; Schvarcz R; Ideo G; Alberti A
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.
Journal of hepatology 1997;26(5):961-6.
1997: Honkoop P; de Man R A; Zondervan P E; Schalm S W
Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.
Liver 1997;17(2):103-6.
1997: Schalm S W
[Health Council report 'Protection against hepatitis B': an opportunity for effective prevention through cooperation]
Nederlands tijdschrift voor geneeskunde 1997;141(7):315-7.
1997: Wolfhagen F H; van Buuren H R; den Ouden J W; Hop W C; van Leeuwen J P; Schalm S W; Pols H A
Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.
Journal of hepatology 1997;26(2):325-30.
1997: Fattovich G; Giustina G; Degos F; Tremolada F; Diodati G; Almasio P; Nevens F; Solinas A; Mura D; Brouwer J T; Thomas H; Njapoum C; Casarin C; Bonetti P; Fuschi P; Basho J; Tocco A; Bhalla A; Galassini R; Noventa F; Schalm S W; Realdi G
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.
Gastroenterology 1997;112(2):463-72.
1997: Schalm S W; Brouwer J T
Antiviral therapy of hepatitis C.
Scandinavian journal of gastroenterology. Supplement 1997;223():46-9.
1996: Schalm S W; Brouwer J T; Chemello L; Alberti A; Bellobuono A; Ideo G; Schwartz R; Weiland O
Interferon-ribavirin combination therapy for chronic hepatitis C.
Digestive diseases and sciences 1996;41(12 Suppl):131S-134S.
1996: Quero J C; Hartmann I J; Meulstee J; Hop W C; Schalm S W
The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
Hepatology (Baltimore, Md.) 1996;24(3):556-60.
1996: Quero J C; Schalm S W
Subclinical hepatic encephalopathy.
Seminars in liver disease 1996;16(3):321-8.
1996: Kooy A; de Heide L J; Engelkens H J; Mulder A H; van Hagen M; Schalm S W
Hepatitis in a patient with SLE: is it autoimmune hepatitis?
The Netherlands journal of medicine 1996;48(4):128-32.
1996: Kooy A; de Heide L J; Engelkens H J; Mulder A H; van Hagen M; Schalm S W
How to diagnose autoimmune hepatitis in systemic lupus erythematosus?
Hepatology (Baltimore, Md.) 1996;23(4):936-8.
1996: Groeneweg M; Gyr K; Amrein R; Scollo-Lavizzari G; Williams R; Yoo J Y; Schalm S W
Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.
Electroencephalography and clinical neurophysiology 1996;98(1):29-34.
1995: de Man R A; Sprey R P; Niesters H G; Heijtink R A; Zondervan P E; Hop W; Schalm S W
Survival and complications in a cohort of patients with anti-delta positive liver disease presenting in a tertiary referral clinic.
Journal of hepatology 1995;23(6):662-7.
1995: Heijtink R A; Snobl J; Kruining J; Kerkhof-Los C; de Man R A; Janssen H L; Schalm S W
Quantitative measurement of HBeAg in chronic hepatitis B: a comparison between a radioimmunoassay, a fluorescence ELISA and a chemiluminescence ELISA.
Journal of medical virology 1995;47(3):245-50.
1995: Grosheide P M; Wladimiroff J W; Heijtink R A; Mazel J A; Christiaens G C; Nuijten A S; Schalm S W
Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. Dutch Study Group on Prevention of Neonatal Hepatitis.
BMJ (Clinical research ed.) 1995;311(7014):1197-9.
1995: Heijtink R A; Kruining J; Weber Y A; de Man R A; Schalm S W
Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assay.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1078-83.
1995: Honkoop P; de Man R A; Heijtink R A; Schalm S W
Hepatitis B reactivation after lamivudine.
Lancet 1995;346(8983):1156-7.
1995: Kleter G E; van Doorn L J; Stuyver L; Maertens G; Brouwer J T; Schalm S W; Heijtink R A; Quint W G
Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western Europe.
Journal of medical virology 1995;47(1):35-42.
1995: Quero J C; Hartmann I J; de Rooij F; Wilson J H; Schalm S W
Hyperammonaemia and Helicobacter pylori.
Lancet 1995;346(8976):713-4.
1995: van Doorn L J; Kleter G E; Stuyver L; Maertens G; Brouwer J T; Schalm S W; Heijtink R A; Quint W G
Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries.
The Journal of general virology 1995;76 ( Pt 7)():1871-6.
1995: Van der Rijt C C; Schalm S W; Meulstee J; Stijnen T
Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
Gastroentérologie clinique et biologique 1995;19(6-7):572-80.
1995: Wolfhagen F H; van Buuren H R; Schalm S W; ten Kate F J; van Hattum J; Eskens F A; den Ouden Muller J W; de Vries R A; Ferwerda J; van der Hoek E W
Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group.
Journal of hepatology 1995;22(3):381.
1995: Kruining J; Heijtink R A; Schalm S W
Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment.
Journal of hepatology 1995;22(3):263-7.
1995: Fattovich G; Giustina G; Schalm S W; Hadziyannis S; Sanchez-Tapias J; Almasio P; Christensen E; Krogsgaard K; Degos F; Carneiro de Moura M
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.
Hepatology (Baltimore, Md.) 1995;21(1):77-82.
1995: Schalm S W; de Man R A; Heijtink R A; Niesters H G
New nucleoside analogues for chronic hepatitis B.
Journal of hepatology 1995;22(1 Suppl):52-6.
1994: del Canho R; Grosheide P M; Voogd-Schotanus M; Huisman W M; Heijtink R A; Schalm S W
Immunogenicity of two different dosages (10 and 5 micrograms) of recombinant DNA hepatitis B vaccine in healthy neonates.
Vaccine 1994;12(14):1323-6.
1994: Koek G H; Stricker B H; Blok A P; Schalm S W; Desmet V J
Flucloxacillin-associated hepatic injury.
Liver 1994;14(5):225-9.
1994: Realdi G; Fattovich G; Hadziyannis S; Schalm S W; Almasio P; Sanchez-Tapias J; Christensen E; Giustina G; Noventa F
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP).
Journal of hepatology 1994;21(4):656-66.
1994: Grosheide P M; del Canho R; Voogd M; Heijtink R A; Schalm S W
Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Vaccine 1994;12(12):1059-63.
1994: Metselaar H J; Tilanus H W; Ijzermans J N; Groenland T N; van den Berg B; Schalm S W
[Criteria for and results of liver transplantation in patients with acute liver insufficiency]
Nederlands tijdschrift voor geneeskunde 1994;138(38):1901-4.
1994: Schalm S W
[Current recommendations on planning of liver transplantations in The Netherlands: the price of lagging behind]
Nederlands tijdschrift voor geneeskunde 1994;138(38):1895-8.
1994: Heijtink R A; Kruining J; de Wilde G A; Balzarini J; de Clercq E; Schalm S W
Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture.
Antimicrobial agents and chemotherapy 1994;38(9):2180-2.
1994: Janssen H L; Brouwer J T; van der Mast R C; Schalm S W
Suicide associated with alfa-interferon therapy for chronic viral hepatitis.
Journal of hepatology 1994;21(2):241-3.
1994: Grosheide P M; Quartero H W; Schalm S W; Heijtink R A; Christiaens G C
Early invasive prenatal diagnosis in HBsAg-positive women.
Prenatal diagnosis 1994;14(7):553-8.
1994: van Doorn L J; Kleter B; Stuyver L; Maertens G; Brouwer H; Schalm S; Heijtink R; Quint W
Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles.
Journal of hepatology 1994;21(1):122-9.
1994: de Knegt R J; Gramsbergen J B; Schalm S W
45CaCl2 autoradiography in brain from rabbits with encephalopathy from acute liver failure or acute hyperammonemia.
Metabolic brain disease 1994;9(2):153-60.
1994: de Rave S; Heijtink R A; Bakker-Bendik M; Boot J; Schalm S W
Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers.
Vaccine 1994;12(6):532-4.
1994: del Canho R; Grosheide P M; Schalm S W; de Vries R R; Heijtink R A
Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates.
Journal of hepatology 1994;20(4):483-6.
1994: Janssen H L; Kerhof-Los C J; Heijtink R A; Schalm S W
Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy.
Antiviral research 1994;23(3-4):251-7.
1994: Wolfhagen F H; van Buuren H R; Schalm S W
Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
The Netherlands journal of medicine 1994;44(3):84-90.
1994: de Knegt R J; Groeneweg M; Schalm S W; Hekking-Weijma I
Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study.
Liver 1994;14(1):25-31.
1994: Kleter G E; van Doorn L J; Brouwer J T; Schalm S W; Heijtink R A; Quint W G
Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands.
Journal of clinical microbiology 1994;32(2):306-10.
1994: de Knegt R J; Schalm S W; van der Rijt C C; Fekkes D; Dalm E; Hekking-Weyma I
Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis.
Journal of hepatology 1994;20(1):19-26.
1993: del Canho R; Grosheide P M; Heijtink R A; Schalm S W
[The course of hepatitis B in 9 children who became positive for viral surface antigen HBsAg in spite of vaccination]
Nederlands tijdschrift voor geneeskunde 1993;137(50):2599-603.
1993: del Canho R; Grosheide P M; Voogd M; Huisman W M; Heijtink R A; Schalm S W
Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes.
Journal of medical virology 1993;41(1):30-4.
1993: Bakker C M; Stibbe J; Gomes M J; Groenland T N; Metselaar H J; Hesselink E J; Schalm S W; Terpstra O T
The appearance of donor heparin in the recipient after reperfusion of a liver graft.
Transplantation 1993;56(2):327-9.
1993: de Man R A; Metselaar H J; Heijtink R A; Schalm S W
Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases.
The Netherlands journal of medicine 1993;43(1-2):74-82.
1993: Janssen H L; Schoenmaker-Weber Y A; Kruining H; Schalm S W; Heijtink R A
Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays.
Journal of medical virology 1993;40(4):307-12.
1993: Grosheide P M; Schalm S W; van Os H C; Fetter W P; Heijtink R A
Immune response to hepatitis B vaccine in pregnant women receiving post-exposure prophylaxis.
European journal of obstetrics, gynecology, and reproductive biology 1993;50(1):53-8.
1993: Groeneweg M; de Knegt R J; Hamberger A; Ding M; Wang S; Schalm S W; Haglid K G
Neuronal and glial marker proteins in encephalopathy associated with acute liver failure and acute hyperammonemia in the rabbit.
Metabolic brain disease 1993;8(2):95-106.
1993: de Knegt R J; Kornhuber J; Schalm S W; Rusche K; Riederer P; Tan J
Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.
Metabolic brain disease 1993;8(2):81-94.
1993: Heijtink R A; De Wilde G A; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm S W
Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Antiviral research 1993;21(2):141-53.
1993: del Canho R; Grosheide P M; Gerards L J; Heijtink R A; Schalm S W
Hepatitis B vaccination and preterm infants.
The Pediatric infectious disease journal 1993;12(5):407-8.
1993: Ginai A Z; van Buuren H R; Hop W C; Schalm S W
Oesophageal varices: how reliable is a barium swallow?
The British journal of radiology 1993;66(784):322-6.
1993: Janssen H L; Berk L; Heijtink R A; ten Kate F J; Schalm S W
Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Hepatology (Baltimore, Md.) 1993;17(3):383-8.
1993: Kleter G E; Brouwer J T; Heijtink R A; Schalm S W; Quint W G
Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon.
Antimicrobial agents and chemotherapy 1993;37(3):595-7.
1993: Bakker C M; Metselaar H J; Gomes M J; Porte R J; Groenland T N; Schalm S W; Terpstra O T; Stibbe J
Intravascular coagulation in liver transplantation--is it present or not? A comparison between orthotopic and heterotopic liver transplantation.
Thrombosis and haemostasis 1993;69(1):25-8.
1993: Janssen H L; Schalm S W; Berk L; de Man R A; Heijtink R A
Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.
Journal of hepatology 1993;17 Suppl 3():S47-51.
1992: de Jongh F E; Janssen H L; de Man R A; Hop W C; Schalm S W; van Blankenstein M
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.
Gastroenterology 1992;103(5):1630-5.
1992: de Rave S; Metselaar H J; Terpstra O T; Schalm S W
Function of partial liver allografts after heterotopic transplantation.
Journal of hepatology 1992;16(1-2):246-7.
1992: Bakker C M; Metselaar H J; Groenland T N; Gomes M J; Knot E A; Hesselink E J; Schalm S W; Stibbe J; Terpstra O T
Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period.
Hepatology (Baltimore, Md.) 1992;16(2):404-8.
1992: Berk L; Schalm S W; Heijtink R A
Zidovudine inhibits hepatitis B virus replication.
Antiviral research 1992;19(2):111-8.
1992: Del Canho R; Grosheide P M; Gerards L J; Heijtink R A; Schalm S W
[Premature infants and hepatitis B vaccination. Study Group Prevention Neonatal Hepatitis B]
Tijdschrift voor kindergeneeskunde 1992;60(4):105-11.
1992: Beukers R; de Rave S; van den Berg J W; Schalm S W
Oral pharmacokinetics of cyclosporin in patients with primary biliary cirrhosis and patients with skin diseases.
Alimentary pharmacology & therapeutics 1992;6(4):459-68.
1992: Janssen H L; Berk L; Schalm S W; Heijtink R A; Hess G; Rossol S; Meyer zum Buschenfelde K H; Chamuleau R A; Jansen P L; Reesink H W
Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.
Gut 1992;33(8):1094-8.
1992: Schalm S W
Eurohep. A European Community sponsored concerted action on viral hepatitis: its rationale and execution.
Journal of hepatology 1992;15(1-2):1-3.
1992: Janssen H L; Berk L; de Man R A; Heijtink R A; Schalm S W
[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B]
Nederlands tijdschrift voor geneeskunde 1992;136(17):835-9.
1992: Blankensteijn J D; Schalm S W; Terpstra O T
New aspects of heterotopic liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5(1):43-50.
1992: Berk L; Schalm S W; de Man R A; Heytink R A; Berthelot P; Brechot C; Boboc B; Degos F; Marcellin P; Benhamou J P
Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial.
Journal of hepatology 1992;14(2-3):305-9.
1992: ten Kate F J; Schalm S W; Willemse P J; Blok A P; Heijtink R A; Terpstra O T
Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study.
Journal of hepatology 1992;14(2-3):168-75.
1992: van der Rijt C C; Schalm S W
Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy.
Journal of hepatology 1992;14(2-3):141-2.
1992: Beukers R; van Zanten R A; Schalm S W
Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis.
Journal of hepatology 1992;14(1):22-9.
1992: Beukers R; Schalm S W
Immunosuppressive therapy for primary biliary cirrhosis.
Journal of hepatology 1992;14(1):1-6.
1992: Willemse P J; Ausema L; Terpstra O T; Krenning E P; ten Kate F W; Schalm S W
Graft regeneration and host liver atrophy after auxiliary heterotopic liver transplantation for chronic liver failure.
Hepatology (Baltimore, Md.) 1992;15(1):54-7.
1992: del Canho R; Schalm S W; Heijtink R A
Hepatitis B revaccination of neonates with inadequate response after primovaccination.
Vaccine 1992;10(1):69.
1991: Berk L; Schalm S W; Heijtink R A
Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses.
Gut 1991;32(10):1198-200.
1991: Grosheide P M; van Osand H C; Schalm S W; Heijtink R A
Immunoprophylaxis to limit a hepatitis B epidemic among women undergoing in vitro fertilization.
Vaccine 1991;9(9):682-7.
1991: Hesselink E J; Metselaar H J; ten Kate F J; Reuvers C B; Schalm S W; Terpstra O T
[Liver transplantation in acute liver insufficiency: definitive replacement or auxiliary liver?]
Nederlands tijdschrift voor geneeskunde 1991;135(27):1233-6.
1991: Metselaar H J; Hesselink E J; Schalm S W; Terpstra O T
[Favorable results of auxiliary heterotopic liver transplantation in patients with end-stage chronic liver insufficiency]
Nederlands tijdschrift voor geneeskunde 1991;135(27):1221-6.
1991: Berk L; de Man R A; Schalm S W; Labadie R P; Heijtink R A
Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed.
Journal of hepatology 1991;12(3):405-6.
1991: Del Canho R; Grosheide P M; Schalm S W
[Hepatitis B virus in schools; a risk?]
Nederlands tijdschrift voor geneeskunde 1991;135(19):862.
1991: Borel Rinkes I H; Van der Hoop A G; Hesselink E J; Metselaar H; De Rave S; Zonderland H M; Schalm S W; Terpstra O T
Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension?
Gastroenterology 1991;100(4):1126-8.
1991: Van der Rijt C C; Schalm S W; Schat H; Foeken K; De Jong G
Overt hepatic encephalopathy precipitated by zinc deficiency.
Gastroenterology 1991;100(4):1114-8.
1991: de Knegt R J; Schalm S W
Fulminant hepatic failure: to transplant or not to transplant.
The Netherlands journal of medicine 1991;38(3-4):131-41.
1991: Metselaar H J; Hesselink E J; de Rave S; Groenland T H; Bakker C M; Weimar W; Schalm S W; Terpstra O T
A comparison between heterotopic and orthotopic liver transplantation in patients with end-stage chronic liver disease.
Transplantation proceedings 1991;23(1 Pt 2):1531-2.
1991: ten Kate F J; Schalm S W
Course of hepatitis delta virus infection in auxiliary liver grafts in patients with delta virus cirrhosis.
Progress in clinical and biological research 1991;364():429-37.
1991: Berk L; de Man R A; Housset C; Berthelot P; Schalm S W
Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta.
Progress in clinical and biological research 1991;364():411-20.
1991: de Man R A; Berk L; Schalm S W; Stijnen T
Treatment of chronic viral hepatitis.
Digestive diseases (Basel, Switzerland) 1991;9(1):17-35.
1990: Baumgartner D; Terpstra O T; Hesselink E J; Groenland T H; Schalm S W; Weimar W; ten Kate F W; Stibbe J; Reuvers C B; Terpstra J L
[Possibilities and limitations of heterotopic auxiliary liver transplantation]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1990;79(51):1594-7.
1990: Janssen H L; Berk L; Vermeulen M; Schalm S W
Seizures associated with low-dose alpha-interferon.
Lancet 1990;336(8730):1580.
1990: de Man R A; Wilson J H; Schalm S W; ten Kate F J; van Leer E
Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis.
Journal of hepatology 1990;11(3):318-21.
1990: Van Berkum F N; Beukers R; Birkenhäger J C; Kooij P P; Schalm S W; Pols H A
Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids.
Gastroenterology 1990;99(4):1134-9.
1990: Smit-Leijs M B; Kramer P; Heijtink R A; Hop W C; Schalm S W
Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma-derived vaccine with and without pre-S2 antigen.
European journal of clinical investigation 1990;20(5):540-5.
1990: van der Rijt C C; de Knegt R J; Schalm S W; Terpstra O T; Mechelse K
Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.
Metabolic brain disease 1990;5(3):131-41.
1990: Metselaar H J; Hesselink E J; de Rave S; ten Kate F J; Lameris J S; Groenland T H; Reuvers C B; Weimar W; Terpstra O T; Schalm S W
Recovery of failing liver after auxiliary heterotopic transplantation.
Lancet 1990;335(8698):1156-7.
1989: Zonderland H M; Laméris J S; Terpstra O T; Ausema L; Krenning E P; Schalm S W; Schütte H E
Auxiliary partial liver transplantation: imaging evaluation in 10 patients.
AJR. American journal of roentgenology 1989;153(5):981-5.
1989: Heijtink R A; de Wilde G A; Kruining J; Smit-Leijs M B; Schalm S W
Anti-pre-S(2) analysis after hepatitis B vaccination in haemodialysis patients.
Antiviral research 1989;12(2):75-86.
1989: Schalm S W
Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1112-4.
1989: Schalm S W; Mazel J A; de Gast G C; Heijtink R A; Botman M J; Bänffer J R; Cerards L J; Zwijnenberg J; Fetter W P; Nuijten S M
Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
Pediatrics 1989;83(6):1041-8.
1989: de Man R A; Lindemans J; Schalm S W; ten Kate F J
beta 2-Microglobulin and antiviral therapy for chronic hepatitis type B.
Antiviral research 1989;11(4):181-90.
1989: De Groot G H; Schalm S W; Fick T; Reuvers C B; Boks A L; Terpstra O T
Strategies for hepatic support in acute liver failure: role of extracorporeal devices versus liver transplantation.
Journal of gastroenterology and hepatology 1989;4(3):283-93.
1989: de Man R A; Schalm S W; van der Heijden A J; ten Kate F W; Wolff E D; Heijtink R A
Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy.
Journal of hepatology 1989;8(3):367-72.
1989: Fick T E; Schalm S W; de Vlieger M
Continuous intravenous ammonia infusion as a model for the study of hepatic encephalopathy in rabbits.
The Journal of surgical research 1989;46(3):221-5.
1989: Heijtink R A; de Wilde G A; van Hattum J; Schalm S W
Long-term immune reactivity to pre-S(2)-antigen after acute hepatitis B infection.
Journal of medical virology 1989;27(2):95-9.
1989: Heijtink R A; Knol R M; Schalm S W
Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.
Journal of medical virology 1989;27(2):151-4.
1989: Alberda A T; van Os H C; Zeilmaker G H; Rothbarth P H; Heijtink R A; Schalm S W
[Hepatitis B virus infection in women treated with in-vitro fertilization]
Nederlands tijdschrift voor geneeskunde 1989;133(1):20-5.
1988: Schalm S W
Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1988;7 Suppl 3():26-9.
1988: Terpstra O T; Schalm S W; Weimar W; Willemse P J; Baumgartner D; Groenland T H; ten Kate F W; Porte R J; de Rave S; Reuvers C B
Auxiliary partial liver transplantation for end-stage chronic liver disease.
The New England journal of medicine 1988;319(23):1507-11.
1988: van Buuren H R; Fick T E; Schalm S W
Recurrent bleeding from cutaneous venous collaterals in portal hypertension.
Gut 1988;29(9):1279-81.
1988: De Man R A; Schalm S W; Heijtink R A; Berk L; Den Ouden J; ten Kate F J; Chamuleau R A; Reesink H W
Long-term follow-up of antiviral combination therapy in chronic hepatitis B.
The American journal of medicine 1988;85(2A):150-4.
1988: Beukers R; Schalm S W
Effect of cyclosporine and cyclosporine plus prednisone in primary biliary cirrhosis.
Transplantation proceedings 1988;20(3 Suppl 4):340-3.
1988: de Rave S; Schalm S W; Willemse P J; Weimar W; Terpstra O T
Cyclosporine in auxiliary partial liver transplantation.
Transplantation proceedings 1988;20(3 Suppl 3):397-400.
1988: Terpstra O T; Reuvers C B; Schalm S W
Auxiliary heterotopic liver transplantation.
Transplantation 1988;45(6):1003-7.
1988: Heijtink R A; Breukers A A; den Hartigh G; Schepman R W; Schmitz P I; Schalm S W; Masurel N
Low dose intradermal vaccination against hepatitis B in mentally retarded patients.
Vaccine 1988;6(1):59-61.
1987: Terpstra O T; Schalm S W; Reuvers C B; Baumgartner D; Groenland T H; ten Kate F J; Stibbe J; Terpstra J L; Weimar W; Willemse P J
The role of auxiliary liver transplantation.
Transplantation proceedings 1987;19(5):4370-2.
1987: Terpstra O T; Ausema B; Bruining H A; Laméris J S; Reuvers C B; Schalm S W; van Urk H; Wilson J H
Late results of mesocaval interposition shunting for bleeding oesophageal varices.
The British journal of surgery 1987;74(9):787-90.
1987: Heijtink R A; Smal P; ten Kate F J; Kruining J; Schalm S W
Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy.
Antiviral research 1987;7(6):329-40.
1987: Heijtink R A; Schalm S W; Kruining J; Tyrrell-Heijgen M J; Bakker P; Boot J; Schmitz P I; Masurel N
Hepatitis B vaccination in health care workers: assessment of simple guidelines.
The Netherlands journal of medicine 1987;30(3-4):117-27.
1987: de Groot G H; Reuvers C B; Schalm S W; Boks A L; Terpstra O T; Jeekel H; ten Kate F W; Bruinvels J
A reproducible model of acute hepatic failure by transient ischemia in the pig.
The Journal of surgical research 1987;42(1):92-100.
1987: Fick T E; Schalm S W; de Vlieger M
A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1987;19(5):276-82.
1986: Schalm S W; Heytink R A; Van Buuren H R; De Man R A
Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
Journal of hepatology 1986;3 Suppl 2():S189-92.
1986: Schalm S W; Heytink R A; Van Buuren H R; De Man R A
Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
Journal of hepatology 1986;3 Suppl 2():S137-41.
1986: Schalm S W
Chronic hepatitis B: diagnosis and treatment.
Postgraduate medical journal 1986;62 Suppl 2():11-20.
1985: van Berlo A M; de Groot G H; Schalm S W; Jansen P P; de Vries E H; Fick T; Reuvers C; Boks A L
In vivo experiments with powder charcoal haemoperfusion (filmadsorber) in a pig model of hepatic failure.
The International journal of artificial organs 1985;8(6):335-40.
1985: Reuvers C B; Terpstra O T; Boks A L; de Groot G H; Jeekel J; ten Kate F W; Kooy P P; Schalm S W
Auxiliary transplantation of part of the liver improves survival and provides metabolic support in pigs with acute liver failure.
Surgery 1985;98(5):914-21.
1985: Schalm S W; Heytink R A; van Buuren H R; de Man R A
Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
Lancet 1985;2(8451):358-60.
1985: Heijtink R A; Kruining J; Schalm S W; Masurel N
Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine study.
Journal of virological methods 1985;10(4):333-9.
1985: Mazel J A; Heijtink R A; Schalm S W; Gerards L J; Botman M J; Bänffer J R; de Gast G C; Nuyten A S; Wladimiroff J W; Zwijnenberg J
[Combined passive and active immunization of infants of HbsAg-positive mothers]
Nederlands tijdschrift voor geneeskunde 1985;129(13):590-4.
1985: Heijtink R A; Kruining J; Bakker M; Schalm S W
Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine.
Antiviral research 1985;Suppl 1():273-9.
1984: Reuvers C B; Terpstra O T; de Groot G H; Kooy P P; ten Kate F W; Schalm S W; Molenaar J C; Jeekel J
Auxiliary transplantation of a partially hepatectomized liver in pigs with fulminant hepatic failure.
Transplantation proceedings 1984;16(5):1236-9.
1984: Mazel J A; Schalm S W; de Gast B C; Nuijten A S; Heijtink R A; Botman M J; Bänffer J R; Gerards L J; Zwijnenberg J; Mettau J
Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations.
British medical journal (Clinical research ed.) 1984;288(6416):513-5.
1983: Heijtink R A; Kruining J; Schalm S W; Masurel N
Hepatitis B: prevaccination screening of individuals simultaneously positive for HBsAg and anti-HBs in one assay.
Lancet 1983;1(8332):1050-1.
1983: De Groot G H; Schalm S W; Dirksen R; Valk K C; Boks A L
Effect of naloxone on shock in a patient with fulminant hepatic failure.
The Netherlands journal of medicine 1983;26(3):77-9.

Sign-in to see more